Description Barinthus Biotherapeutics
Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing immunotherapeutic candidates and vaccines for infectious diseases, autoimmunity, and oncology. The company is headquartered in the United Kingdom and its shares trade on Nasdaq.